Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Greenwald

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Anesthesiology|May 2, 2012
Hospital stay and mortality are increased in patients having a "triple low" of low blood pressure, low bispectral index, and low minimum alveolar concentration of volatile anesthesiaDaniel I Sessler, Jeffrey C Sigl, Scott D Kelley, et al.
Anesthesiology|September 21, 2022
Risk Stratification Index 3.0, a Broad Set of Models for Predicting Adverse Events during and after Hospital AdmissionScott Greenwald, George F Chamoun, Nassib G Chamoun, et al.
Anesthesiology|December 20, 2022
Extended-age Out-of-sample Validation of Risk Stratification Index 3.0 Models Using Commercial All-payer ClaimsScott Greenwald, George F Chamoun, Nassib G Chamoun, et al.
Journal of Psychopharmacology (Oxford, England)|September 8, 2012
Examination of Org 26576, an AMPA receptor positive allosteric modulator, in patients diagnosed with major depressive disorder: an exploratory, randomized, double-blind, placebo-controlled trialKari R Nations, Peter Dogterom, Roberta Bursi, et al.
The Journal of Clinical Psychiatry|February 20, 2013
Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) trialIan A Cook, Aimee M Hunter, William S Gilmer, et al.
Investigative Ophthalmology & Visual Science|June 3, 2008
Factors affecting perceptual thresholds in epiretinal prosthesesChloé de Balthasar, Sweta Patel, Arup Roy, et al.
Psychiatry Research|August 28, 2009
Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorderAndrew F Leuchter, Ian A Cook, William S Gilmer, et al.
Psychiatry Research|August 29, 2009
Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD studyAndrew F Leuchter, Ian A Cook, Lauren B Marangell, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Anesthesiology|May 2, 2012
Hospital stay and mortality are increased in patients having a "triple low" of low blood pressure, low bispectral index, and low minimum alveolar concentration of volatile anesthesiaDaniel I Sessler, Jeffrey C Sigl, Scott D Kelley, et al.
Anesthesiology|September 21, 2022
Risk Stratification Index 3.0, a Broad Set of Models for Predicting Adverse Events during and after Hospital AdmissionScott Greenwald, George F Chamoun, Nassib G Chamoun, et al.
Anesthesiology|December 20, 2022
Extended-age Out-of-sample Validation of Risk Stratification Index 3.0 Models Using Commercial All-payer ClaimsScott Greenwald, George F Chamoun, Nassib G Chamoun, et al.
Journal of Psychopharmacology (Oxford, England)|September 8, 2012
Examination of Org 26576, an AMPA receptor positive allosteric modulator, in patients diagnosed with major depressive disorder: an exploratory, randomized, double-blind, placebo-controlled trialKari R Nations, Peter Dogterom, Roberta Bursi, et al.
The Journal of Clinical Psychiatry|February 20, 2013
Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) trialIan A Cook, Aimee M Hunter, William S Gilmer, et al.
Investigative Ophthalmology & Visual Science|June 3, 2008
Factors affecting perceptual thresholds in epiretinal prosthesesChloé de Balthasar, Sweta Patel, Arup Roy, et al.
Psychiatry Research|August 28, 2009
Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorderAndrew F Leuchter, Ian A Cook, William S Gilmer, et al.
Psychiatry Research|August 29, 2009
Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD studyAndrew F Leuchter, Ian A Cook, Lauren B Marangell, et al.
Pageof 2